| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.2M | +9464.1% |
| R&D Expense | $16.7M | +14.4% |
| SG&A Expense | $11.1M | +9.0% |
| Operating Income | -$24.6M | +0.6% |
| Net Income | -$21.0M | +9.8% |
| EPS (Basic) | -$0.10 | +9.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.8M | -67.5% |
| Short-term Investments | $21.9M | -23.3% |
| Current Assets | $34.5M | -32.3% |
| Total Assets | $44.8M | -26.9% |
| Current Liabilities | $4.3M | -1.4% |
| Total Liabilities | $8.2M | -7.4% |
| Stockholders' Equity | $36.6M | -30.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$19.2M | -25.8% |
| Capital Expenditures | $892K | +242.6% |
| Investing Cash Flow | $4.9M | -70.9% |
| Financing Cash Flow | $79K | -98.9% |
| Free Cash Flow | -$20.0M | -29.5% |